Recent Therapeutic Updates on Non-Muscle Invasive Bladder Cancer (NMIBC)

Evaluation of intravesical Bacillus Calmette–Guerin (BCG) treatment on outcomes of patients with T0 after repeat Transurethral resection of bladder mass (re-TURBT) with high-risk NMIBC.